The increasing incidences of type 2 diabetes mellitus, represents a considerable public health problem and characterized by loss in sensitivity of tissues to insulin which can be restored by activation of Peroxisome Proliferator-Activated Receptors (PPARs). The present work takes in consideration for the development of PPAR agonists, which can activate PPARs and is expected to lower LDL cholesterol and triglycerides, raise HDL cholesterol and normalize hyperglycaemia. Materials and Methods: Quantitative Structure-Activity Relationship (QSAR) study is performed by means of Multiple Linear Regression (MLR) analysis on a set of indanyl acetic acid derivatives followed by ADMET prediction and Docking Studies. Results: A good correlation is found by regression analysis between the observed and predicted activities as evident by their R 2 (0.81), Q 2 (0.81) and R 2 pred (0.86) for PPARα and R 2 (0.66), Q 2 (0.66) and R 2 pred (0.90) for PPARδ and R 2 (0.82), Q 2 (0.77) and R 2 pred (0.58) for PPARγ respectively. Molecular docking of the ligands qualifying all the Drug Likeness properties to the proteins PPARα (PDB ID: 3ET1), PPARδ (PDB ID: 3ET2) and PPARγ (PDB ID: 3ET3) with FlexX score -11.98, -9.69 and -21.48 respectively followed by core hoping. Conclusion: Docking studies revealed that hydrogen-bonding interactions are crucial for the binding of ligands with the target. Core replacement of the best-docked conformations of the selected ligand is performed in order to obtain more potent and novel ligands.
INTRODUCTION
Type 2 Diabetes Mellitus (T2DM) is an important public health problem, one of four priority Non-Communicable Diseases (NCDs) targeted for action by world leaders. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades. 1, 2 Worldwide, almost 0.422 billion grown-ups are existing with T2DM in 2014, as compared to 0.108 billion in 1980. 3 The overall occurrence (age-standardized) of T2DM has approximately doubled since 1980, escalating from 4.7% towards 8.5% in 2014 in the population of adult. 4, 5 India has been termed as the "Diabetes capital of the world" as it is lead-on target cells as their actions are restricted to specific tissue types. [11] [12] [13] All three receptors are important regulators in multiple physiological pathways, such as glucose homeostasis, fatty acid metabolism, inflammation and cellular differentiation. 14, 15 Activation of PPARs improves the condition of insulin resistance and therefore PPARs became a primary target in the treatment of type 2 diabetes. 16 Derivatives of indanyl acetic acid are synthetic ligands which exhibit unique PPAR agonistic activities. 17 Structure and ligand-based approaches have been successfully employed in the development of new drugs. 18 The computational methods in drug discovery collectively termed pharmacoinformatics includes Structure-Activity Relationship, 19 virtual screening, 20 molecular docking 21 and ADMET prediction 22 have proven their pivotal role in the pharmaceutical industry for lead identification and optimization. Several research groups worldwide identified PPAR agonists using pharmacoinformatics approaches for potential application for the treatment of T2DM. In the present study, these pharmacoinformatic techniques are used to identify important features necessary for a compound to behave as an activator of PPAR-α, PPAR-γ and PPAR-δ/β receptors. 10, 23 
MATERIALS AND METHODS

Dataset
A set comprising of 69 indanyl acetic acid compounds bearing substituted phenyl tail groups, 4-heteroarylsubstituted aryl tail groups and thiazolylphenyl groups is taken from the available literature and used in the present study. 17 The selected compounds for the data set shared the same assay i.e. FRET assay procedure with significant variations in their structures and potency profiles. The half-maximal effective concentration of the compounds included in data set, with EC 50 values varying from 47 to 10000 nM, 0.58 to 2230 nM and 12 to 10000 nM for PPARα, δ and γ subtypes respectively which are converted into molar values. These are then converted into pEC 50 values using the formula given below.
The structures of ligands are generated using the Chem Draw Ultra 7.0 software package. 24 The energy minimization is performed for each ligand using the Chem3Dultra software. The X-ray crystal structure of the PPAR receptor is obtained from the Protein Data Bank (PDB ID: 3ET1, 3ET2 and 3ET3). 25, 26 The active site coordinates of the co-crystallized ligand are used for molecular docking studies to calculate the docking scores using FlexX algorithms. 27 The FlexX program is used for docking of the receptor with the ligands qualifying all the drug-likeness filters like Lipinski's rule, Ghose filter, veber rules as well as a Quantitative Estimate of Drug-likeness (QED) calculated using DruLiTo software. 28
Multiple Linear Regression
MLR analysis is a method for establishing the relationship between a single dependent variable and collection of independent variables (or predictors). 29, 30 It relies on the assumption that the variation in molecular properties of compounds can be related to changes in their structural/physicochemical properties. 31 The optimized structures are used for all subsequent calculations. The EC 50 data on indanyl acetic acid derivatives (Table 1) are grabbed from the literature. 17 the dataset is randomly divided into a training set for creating QSAR models and a test set for the validation of the excellence of the models. All compounds in the test set contain the Biological Activity (BA) within the maximum and minimum value range of the BA of training set compounds.
Physicochemical properties of Active Compounds
Bad pharmacokinetic properties are one of the major cause for cessation of the generation of drug candidates. The drug detrition is a significant issue at clinical stages of drug development due to insufficient pharmacokinetics and pharmacodynamics examination. Numerous physicochemical properties like drug-like properties and toxicity of all the compounds in the dataset are evaluated employing the open source tools such as DruLiTo. 28
Molecular Docking
The three-dimensional crystal structures of three selected molecular targets involved in the regulation of glucose homeostasis are obtained from PDB. 25 The receptors are prepared by removal of heteroatoms such as water, ions and addition of polar hydrogens using the FlexX software. 27 The active site is defined as including all atoms within a 6.5 A° radius of the co-crystallized ligand. The docking scores (FlexX-Score) of the ligands are computed from the FlexX docked ligand-receptor complexes. Docking studies are performed for 100 generations and the energetically favorable conformations are analyzed. One complex structure for every ligand is selected as the best fit based on the orientations of ligand and its score is added to the molecular spreadsheet.
Fragment-Based Drug Design
The ReCore module developed by BioSolveIT is a useful suite for Fragment-Based Drug Design (FBDD). 32 This module alters hit ligands by replacing their core. 3D Fragments are generated to replace the core using a vector-based scheme and the resulting structures are scored using the FlexX docking program. 33, 34 Recore offers constructive hopping of scaffold, replacement of 3D core and linking and merging of the fragment. ReCore delivers back a rank-sorted list of fragments within seconds (depending on the complexity of the query). The hit fragments are sorted according to how well they comply with the query using a multidimensional Euclidean distance.
RESULTS AND DISCUSSION
The substituted indanyl acetic acid derivatives reportedly exhibit strong agonistic activities against PPARs. In the current study, we examined only the agonistic activities against PPARs using 2DQSAR studies, specifically MLR and molecular docking scores.
MLR Analysis
The MLR models are derived for a dataset of 69 PPAR activators. The statistical parameters associated with the MLR analysis of PPARα, PPARβ/δ and PPARγ, represented by respective model I, II and III are listed in Table 2 . The prediction ability of models is determined using a set of test compounds not included in the model generation. The values of experimental and predicted activities of all models are depicted in Table 1 . The graphs of actual activity versus predicted activity of the training set and test set for all models are illustrated in Figure 1 . Model 3 represents the MLR equation for PPAR-γ agonists which reveals that vol (van der Waals volume) and BCUT_SMR_3 (atomic contribution to molar refractivity) descriptors positively affects the activity of ligands while the negative value of lip_don (The number of OH and NH atoms) and BCUT_SLOGP_1 (atomic contribution to logP) descriptor indicates that increase in lip_don and BCUT_SLOGP_1 is responsible for an increase in the activity of the molecule.
ADMET Prediction
Distinct pharmacokinetic characteristics of the compounds considered for the study are subjected to ADME predictions by DruLiTo. The compounds are assessed for their fundamental parameters of Lipinski's rule of 5 and furthermore various pharmacokinetic properties. 35 Table 3 shows the results obtained from DruLiTo with their permissible range. In general, an orally dynamic compound ought not to have more than 2 infringement of the Lipinski rule. The dynamic test compounds in the present study are not found disregarding the most extreme permissible limits of Lipinski rule and in this way demonstrating their drug likeliness properties. The ideal estimations of the descriptors, rotatable bonds and polar surface area likewise have an extraordinary impact on the oral bioavailability of the drug atoms. The important parameters with their permissible ranges are delineated in Table 3 . The compounds C5, C7, C16 and C18 qualifying all the ADME filters are further used for docking Analysis.
Molecular Docking
PPARα: The compounds qualifying all the ADME filters are further used for docking Analysis using FlexX software. All four compounds are docked for its binding interactions in the active site of (PDB 3ET1) protein.
The binding pocket consisted of TYR464, TYR314, HIS440, PHE273, GLN277, CYS276, ILE354, SER280, etc. residues in the targeted protein as shown in Figure  2 . For the interaction between ligands and receptor, the presence of a hydrogen bonding feature is found very crucial which is also observed in the QSAR studies. Residue TYR464 and TYR314 are found to show favorable interaction, including HB acceptor and HB donor with the best conformers. The TYR464 and TYR314 residues in receptor binding pocket interacts with the oxygen atom of the carboxyl group of conformers of compounds C5, C7, C16 and C18 with FlexX score -11.16, -12.17, -11.98 and -9.65 respectively. PPARδ: The minimum binding energy indicates that the PPARδ receptor (PDB 3ET2) is successfully docked with indanyl acetic acid derivative is shown in Table  2 . The possible binding modes of indanyl acetic acid derivative at PPARδ active sites have been shown in Figure 2 . PPARδ protein residues TYR437, HIS287, HIS413, CYS249, PHE246, LEU433, etc. formed active site in the protein. Residue TYR437, HIS413 and HIS287 found to form H-bond with the ligand molecules. Ligand showed relatively good binding affinity as compared to the natural ligand as standard which showed minimum binding energy shown in Table 2 . PPARγ: To further observe the interactions, the compounds are docked for its binding interactions with the active site of (PDB 3ET3) protein. To calculate the docked scores of the agonist structures against PPARγ, the molecular docking program FlexX is employed. In the current study, 100 conformational binding modes are generated for each ligand at the active site and the number of HB interactions are observed. The docked conformation of compounds revealed that the compound interacted with the binding pocket residues (TYR473, HIS449, HIS323, ARG288, CYS285, etc.) of receptor through several favorable interactions such as HB donor and acceptor with residue TYR473, HIS449 and HIS323 respectively as shown in Figure 2 . The binding affinity of ligands is shown in Table 2 .
Fragment-Based Drug Design using Recore
The ReCore module is used to modify the best docked hit C16 compounds by replacing their core. Fragments utilized to replace the chemical scaffold are generated in 3D, to cut and replace the fragment, a vector based scheme is used. To score the resulting structures the FlexX docking program is used. The starting hit compound is altered with linker fragments that possess similar functional groups; The new fragment is grafted onto the starting fragment by overlapping. As a result, various compounds obtained out of which the bestscored compound is analyzed using FlexX. It is interesting to note that compound containing ZINC03584559 36 in core exhibited better scores than the natural ligand and the other docked highly active compounds as shown in Table 2 . The binding poses for the interaction are shown in Figure 3 .
CONCLUSION
The combined computational approaches are applied to give insight into the structural basis and activation mechanism for a series of indanyl acetic acid derivatives as anti-diabetic agents. QSAR modeling is performed to provide a structural framework for understanding the structure-activity relationship of these compounds. The 2D-QSAR generated models exhibited good predictive power, correlation and satisfactory agreement between theory and experiment. Further, ADME predictions are performed for the set of compounds followed by molecular docking studies to generate possible binding poses for these compounds to PPARs. Conclusively, the hits obtained on virtual screening of the zinc database using RECORE module have provided new chemical starting points for design and development of novel PPAR targeting agents.
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